COMBINED INHIBITION OF EGFR AND MEK REVERSES EGFR ANTIBODY RESISTANCE

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2014年 / 4卷 / 04期
关键词：
D O I：
10.1158/2159-8290.CD-RW2014-053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：389 / 389
页数：1
相关论文
共 50 条
  • [1] Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR-Mutant Lung Cancer
    Tricker, Erin M.
    Xu, Chunxiao
    Uddin, Sharmeen
    Capelletti, Marzia
    Ercan, Dalia
    Ogino, Atsuko
    Pratilas, Christine A.
    Rosen, Neal
    Gray, Nathanael S.
    Wong, Kwok-Kin
    Jaenne, Pasi A.
    [J]. CANCER DISCOVERY, 2015, 5 (09) : 960 - 971
  • [2] Combined MEK and EGFR inhibition demonstrates synergistic activity in EGFR-dependent NSCLC
    Balko, Justin M.
    Jones, Brett R.
    Coakley, Virginia L.
    Black, Esther P.
    [J]. CANCER BIOLOGY & THERAPY, 2009, 8 (06) : 522 - 530
  • [3] EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells
    Xiaoping He
    Yohko Hikiba
    Yoshimasa Suzuki
    Yoshinori Nakamori
    Yushi Kanemaru
    Makoto Sugimori
    Takeshi Sato
    Akito Nozaki
    Makoto Chuma
    Shin Maeda
    [J]. Scientific Reports, 12
  • [4] EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells
    He, Xiaoping
    Hikiba, Yohko
    Suzuki, Yoshimasa
    Nakamori, Yoshinori
    Kanemaru, Yushi
    Sugimori, Makoto
    Sato, Takeshi
    Nozaki, Akito
    Chuma, Makoto
    Maeda, Shin
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [5] Combined EGFR and MEK inhibition prevents the emergence of drug resistance in EGFR mutant non-small cell lung cancer (NSCLC)
    Tricker, Erin M.
    Xu, Chunxiao
    Ercan, Dalia
    Ogino, Atsuko
    Wong, Kwok-kin
    Janne, Pasi
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [6] Primary and Acquired Resistance of Colorectal Cancer Cells to Anti-EGFR Antibodies Converge on MEK/ERK Pathway Activation and Can Be Overcome by Combined MEK/EGFR Inhibition
    Troiani, Teresa
    Napolitano, Stefania
    Vitagliano, Donata
    Morgillo, Floriana
    Capasso, Anna
    Sforza, Vincenzo
    Nappi, Anna
    Ciardiello, Davide
    Ciardiello, Fortunato
    Martinelli, Erika
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (14) : 3775 - 3786
  • [7] Porocarcinoma expression of high EGFR levels and sensitivity to EGFR or/and MEK inhibition.
    Meier, Friedegund Elke
    Sergon, Mildred
    Garzarolli, Marlene
    Ruetten, Arno
    Blum, Sophia
    Laniado, Michael
    Ugurel, Selma
    Maschke, Jan
    Beissert, Stefan
    Kulms, Dagmar
    Westphal, Dana
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cells
    Liu, Bi-Sheng
    Xia, Hong-Wei
    Zhou, Sheng
    Liu, Qing
    Tang, Qiu-Lin
    Bi, Na-Xi
    Zhou, Ji-Tao
    Gong, Qi-Yong
    Nie, Yong-Zhan
    Bi, Feng
    [J]. ONCOLOGY REPORTS, 2018, 40 (04) : 2171 - 2182
  • [9] Porocarcinomas express EGFR and are sensitive to EGF and/or MEK Inhibition
    Garzarolli, M.
    Sergon, M.
    Ruetten, A.
    Blum, S.
    Maschke, J.
    Beissert, S.
    Meier, F.
    Westphal, D.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 20 - 20
  • [10] Combinational inhibition of EGFR and YAP reverses 5-Fu resistance in colorectal cancer
    Huang, Changhao
    Chen, Zihua
    Yang, Chen
    Chen, Lu
    Lai, Chen
    Zhang, Yingying
    Yuan, Weijie
    Jeong, Ji-Hak
    [J]. JOURNAL OF CANCER, 2020, 11 (18): : 5432 - 5439
12345